T1	Premise 1204 1357	After a median follow-up time of 9.64 months, incidence rates of grades 2-4 acute diarrhea were similar in both groups (49% placebo vs 44% LAO; P = .21).
T2	Premise 1358 1532	No statistically significant treatment differences in chemotherapy or radiation delivery, medical resource utilization, patient-reported bowel function, or QoL were observed.
T3	Claim 1533 1709	In this study, the prophylactic use of LAO did not prevent the incidence or reduce the severity of diarrhea and had no notable impact on patient-reported bowel function or QoL.
R1	Support Arg1:T2 Arg2:T3	
R2	Support Arg1:T1 Arg2:T3	
